COVID-19 Retrospective Study of Chest CTs from China: What is the Re…

Adam Bernheim

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

Modern Management of the LSCA in TEVAR

UPMC

M. Farber

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Hypertrophic Cardiomyopathy: the Past, the Present, and the Future

Canadian Collaborative Research Network

E. Braunwald

The Valve Trials Are Done: Interventional HFpEF Is the Next Big Thing

Northwestern Medicine Bluhm Cardiovascular Institute

S. Shah